NCT00005943View on ClinicalTrials.gov

Gene Therapy in Treating Patients With Metastatic Melanoma

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

February 29, 2000

Primary Completion Date

September 30, 2001

Study Completion Date

September 30, 2001

Conditions
Melanoma (Skin)
Interventions
BIOLOGICAL

aldesleukin

BIOLOGICAL

staphylococcal enterotoxin B

Trial Locations (1)

80262

University of Colorado, Denver

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

University of Colorado, Denver

OTHER

NCT00005943 - Gene Therapy in Treating Patients With Metastatic Melanoma | Biotech Hunter | Biotech Hunter